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Precisely deciphering the molecular mechanisms of
age-related memory loss is crucial to create appro-
priate therapeutic interventions. We have previously
shown that the histone-binding protein RbAp48/
Rbbp4 is a molecular determinant of Age-Related
Memory Loss. By exploring how this protein regu-
lates the genomic landscape of the hippocampal cir-
cuit, we find that RbAp48 controls the expression of
BDNF and GPR158 proteins, both critical compo-
nents of osteocalcin (OCN) signaling in the mouse
hippocampus. We show that inhibition of RbAp48 in
the hippocampal formation inhibits OCN’s beneficial
functions in cognition and causes deficits in discrim-
ination memory. In turn, disruption of OCN/GPR158
signaling leads to the downregulation of RbAp48 pro-
tein, mimicking the discrimination memory deficits
observed in the aged hippocampus. We also show
that activation of the OCN/GPR158 pathway in-
creases the expression of RbAp48 in the aged den-
tate gyrus and rescues age-related memory loss.
INTRODUCTION
Normal aging produces significant alterations in hippocampal cir-
cuitry, thereby leading to deficits in key components of episodic
memory (Leal and Yassa, 2015). Studies in human and in mouse
model systems have established that aging may lead to spatial
memory impairment (Bach et al., 1999; Pavlopoulos et al., 2013;
Small et al., 2004) and to deficits in pattern separation/completion
processes (Clark et al., 2017; McAvoy et al., 2016; Stark et al.,
2013). Imbalances between pattern separation and pattern
completion, which are mediated by the dentate gyrus (DG) andCell
This is an open access article under the CC BY-Nthe CA3 hippocampal sub-regions, ultimately contribute to mem-
orydeficitsand toage-relatedmemory loss (Leal andYassa,2015).
Learning and memory formation and maintenance are com-
plex processes that are tightly controlled at the cellular level by
regulation of gene expression, which in turn can be affected by
DNAmodifications such as histone acetylation and DNAmethyl-
ation (Alarco´n et al., 2004; Guan et al., 2002). Cellular aging has
also been associatedwith DNA changes and remodeling of chro-
matin architecture, leading to deregulation of gene transcription
programs and perturbations to cellular homeostasis (Pegoraro
and Misteli, 2009); transcription of several hippocampal plas-
ticity-dependent genes, including ARC, ZIF268, and BDNF, is
also governed by similarmodifications, such as DNAmethylation
or histone acetylation (Penner et al., 2011). Deregulation of plas-
ticity-dependent genes in brain regions susceptible to the aging
process may therefore contribute to age-related cognitive
deficits.
Decrease in histone-binding protein Rbbp4/RbAp48 expres-
sion is a molecular hallmark of normal age-related memory
loss in humans and in wild-type mice. Inhibition of RbAp48
function interferes with its capacity for histone interaction and
recapitulates age-related memory loss in young mice. Overex-
pression of RbAp48 in the DG of older mice alleviates the
cognitive deficits of aging and restores histone acetylation
(Pavlopoulos et al., 2013). Despite its unequivocal importance,
the signaling cascades responsible for the dysregulation of
RbAp48 in age-related memory loss remain unknown.
Here, we explore the molecular mechanisms of RbAp48 func-
tion in the brain and its role in age-related memory loss. RbAp48
was found to control the expression of GPR158, a G-protein-
coupled receptor (GPCR) protein involved in osteocalcin (OCN)
signaling in the brain (Khrimian et al., 2017). In turn, GPR158/
OCN signaling regulates RbAp48 expression in the hippocampal
formation. We show that the OCN/GPR158/RbAp48 signaling
pathway acts on the DG/CA3c and CA3a brain regions to modu-
late contextual fear discrimination and completion, respectively.Reports 25, 959–973, October 23, 2018 ª 2018 The Author(s). 959
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Finally, we find that activation of this signaling pathway in the
aged DG alleviates the cognitive deficits associated with aging.
RESULTS
RbAp48 Is Involved in OCN Signaling and Regulates the
Levels of GPR158
We first aimed to identify the genomic loci of RbAp48 binding in
the mouse DG. We performed chromatin immunoprecipitation
experiments coupled with deep sequencing. Analysis of two bio-
logical replicates revealed that RbAp48 binds mainly to hetero-
chromatin regions and particularly to olfactory receptor genes,
consistent with the well-described role of RbAp48 in repression
complexes (Loyola and Almouzni, 2004; Yamada et al., 2014).
Since other biological functions of RbAp48 protein could have
been masked by its olfactory receptor genes interactions, we
excluded olfactory receptor genes from our analysis andmerged
the two biological replicates to increase the number of the poten-
tial RbAp48 binding sites.We found that RbAp48 protein binds to
7,179 sites (Table S1, RbAp48 binding sites related to Figure 1).
14% of these sites were around gene promoters (/+ 5 kb from
transcription start sites [TSSs]), 18%werewithin gene coding se-
quences, and 68%were intergenic—enhancer binding sites (Fig-
ure 1A). Gene ontology analysis revealed neuronal pathways
such as perception of taste, nervous system development, and
learning (Figure 1B and Table S2, gene ontology and pathways
analysis of RbAp48 chromatin immunoprecipitation sequencing
[ChIP-seq] related to Figure 1). Since RbAp48 participates in
several transcriptional complexes (NuRD, PRC2, etc.), we sur-
veyed our results for RbAp48 binding sites in genes already impli-
cated in age-related memory loss. We focused on the BDNF
locus, because its expression decreases with aging (Rowe
et al., 2007), and on the GPCR GPR158, since it mediates the
beneficial actions of the bone-derived hormone OCN in age-re-
lated memory loss by controlling BDNF protein levels in the
mouse hippocampus (Khrimian et al., 2017) (Figure 1C). Using
ChIP-qPCR, we found that RbAp48 occupies the P5 BDNF pro-
moter and the GPR158 promoter and within the gene (intron) (Fig-
ures 1D–1F). To verify our results, we used a transgenic mouse
model of inhibition of RbAp48 function, where a truncated form of
RbAp48 lacking the first 54 aa responsible for binding to histones,
is overexpressed in forebrain neurons under theCamk2-tTA trans-
gene (referred to as dominant-negative mice [DT]). Expression of
this transgenic formof RbAp48 is suppressed in presenceof doxy-
cycline (Pavlopoulos et al., 2013). Western blot and immunohisto-
chemistry experiments revealed a reduction in the protein levels of
GPR158 in the hippocampus of DT mice compared with single
transgenic (ST) controls (Figures 1G–1I). (DT mice bear two trans-
genes required for RbAp48 overexpression, whereas ST mice
only one). We next wondered whether RbAp48 is part of the OCN
signaling cascade, which controls GPR158 and BDNF protein
levels. Therefore, we measured GPR158 and BDNF mRNA levels
in DT and ST mice 24 hr after PBS or OCN injection in the DG.
GPR158 mRNA levels were significantly decreased in the DG of
the DT mice compared to ST controls (Figure 1J).
In order to further correlate our molecular findings with OCN
signaling and RbAp48, we examined whether inhibition of
RbAp48 blocks BDNF expression in the DG (Khrimian et al.,960 Cell Reports 25, 959–973, October 23, 20182017; Liu et al., 2004). We detected BDNF upregulation both in
the mRNA and protein levels only in the DG of ST animals injected
with OCN (Figures S1A and S1B), but not in the DG of DT animals.
We also measured the RbAp48 mRNA levels in the same animals
and founda significant increaseuponOCN injection in theDG (Fig-
ureS1C) incontrol STmice,whichwascompletely abolished in the
DT RbAp48mice, further demonstrating that RbAp48 participates
in OCN signaling.
OCN Increases RbAp48 in the DG and Enhances Fear
Expression during Context Re-exposure in a Contextual
Fear Conditioning Paradigm
Since OCN injection increased RbAp48 mRNA levels in the DG,
we testedwhether the presence of OCN in the DG can also affect
the expression of RbAp48 protein. We injected OCN directly into
the DG of 3-month-old mice, and we observed a modest in-
crease in RbAp48 in the DG compared with PBS-injected con-
trols within 24 hr (Figures 2A and 2B).
Similarly, 24-hr treatment with OCN in hippocampal neuronal
cultures (17 days in vitro [DIV]) produced a nuclear accumulation
of RbAp48 compared with control-treated neurons and upregu-
lation of PSD95 protein (Figures S2A–S2C) consistent with the
notion that OCN enhances long-term potentiation (LTP) in pyra-
midal cells of the CA3 region via a synaptic specific mechanism
(Khrimian et al., 2017).
We next wondered whether upregulation of RbAp48/PSD95
upon OCN administration in the DG can affect memory. We used
a transgenic c-FosCreERT2/tdTomato reporter mouse line to label
activity-dependent neurons (c-Fos+) and their processes with
tdTomato red fluorescent protein (Guenthner et al., 2013). We
argued that since OCN can regulate cFos expression and LTP in
theCA3aregion throughbinding to theGPR158receptor (Khrimian
et al., 2017), the use of this transgenic mouse would be a suitable
tool to visualize any synaptic effects of OCN administration. We
subjected the c-FosCreERT2/tdTomato line to an experimental
setting illustrated in Figure 2C. OCN administration in the DG
increased the percentageof freezing compared to control (Figures
2D and 2E). The numbers of c-Fos+ cells were not significantly
different between the two groups (Figure S2D), showing that our
manipulationhadasimilar numberofactivationofcFos throughout
theexperimental setting.Since thenumberof labeledneuronswas
the same and OCN administration was directed into the whole
DG/CA3a region, we measured the number of spines in the
tdTomato-positive neurons to examine any plasticity-depended
effects of OCN. OCN-treated mice had more dendritic spines
thanthePBS-treatedcontrols (Figures2Fand2G).Taken together,
these results suggest that (1) OCN regulates the RbAp48 protein,
which in turn controls the expression of GPR158; (2) OCN admin-
istration in theDG/CA3chippocampal regioncan lead toenhanced
7-day fear-memory recall; and (3) OCN administration coupled
with a fear memory recall behavioral task can lead to increased
spine formation in neurons of the outer molecular layer of the DG.
OCNSignalingModulates Learning andMemory through
an RbAp48-Dependent Mechanism in the DG/CA3
Having found that RbAp48 participates in GPR158/OCN
signaling, and that RbAp48 regulates GPR158 expression, we
asked whether histone binding by RbAp48 is essential to
Figure 1. RbAp48 Controls GPR158 and OCN Signaling
(A) Distribution of RbAp48 binding sites in the mouse genome.
(B) Top ten biological processes for genes that RbAp48 binds to.
(C) Peaks in the mouse genome for RbAp48 binding compared with the input DNA for BDNF and GPR158 loci.
(D–F) Quantitative real-time PCR of ChIP assays from dentate gyrus (DG) lysates for the GPR158 promoter (D), the GPR158 intron (E), and P5 BDNF promoter (F)
compared to input DNA (n = 6 mice per group). Fold enrichment of RbAp48 binding in the respective genomic regions (one-way ANOVA treatment between
columns post hoc Bonferroni; p = 0.0129, p = 0.0275, p = 0.0036, respectively).
(G) Western blot images of GPR158, transgenic Flag-tagged DN-RbAp48, and tubulin proteins from hippocampal lysates from control (ST) and dominant-
negative RbAp48 overexpression mice (DT).
(H) Quantification of GPR158 protein levels (unpaired t test, p = 0.0038; n = 6 mice per group).
(I) Representative images of the DG of DT and ST mice stained for GPR158 and RbAp48 (scale bar, 20 mm).
(J) Quantitative real-time PCR of GPR158 mRNA from the DG/CA3c of ST or DT mice injected with PBS or OCN. GPR158 mRNA is downregulated in the DG of
DTmice compared to ST controls injected with PBS (one-way ANOVA treatment between columns post hoc Bonferroni; n = 4–5mice per treatment, respectively;
p = 0.0113).
All data represent means ± SEM. *p < 0.05, **p < 0.01.
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Figure 2. OCN Increases RbAp48 in the DG and Enhances Fear Expression during Context Re-exposure (Contextual Fear Conditioning)
(A) Images of the DG stained for RbAp48 (red) 24 hr after administration of PBS (top) or OCN (bottom) in the DG (scale bar, 100 mm).
(B) OCN injection increases RbAp48 24 hr after an injection (unpaired t tests; n = 8 mice per group; p = 0.0103).
(C) Schematic representation of contextual fear conditioning (CFC) in c-FosCreERT2 3 tdTomato mice.
(D) Images from DG of c-FosCreERT2/tdTomato mice stained for mCherry (red) PBS (left) or OCN (right) (scale bar, 100 mm).
(E) c-FosCreERT23 tdTomatomicewere administered a three-shockCFCparadigm.OCNadministration did not affect fear acquisition behavior, but it resulted in
increased fear expression during context re-exposure (unpaired t tests; n = 6 mice per group; p = 0.016).
(F) Images from c-Fos+ dendrites in the outer molecular layer (OML), OCN (right) and PBS (left) (scale bar, 10 mm).
(G) Quantification of spines in c-Fos-+ dendrites in the OML, OCN (right) and PBS (left). OCN increased spine density in c-Fos+ neurons (unpaired t tests; n = 3
mice per group; p = 0.0146; <35 dendrites per animal).
All data represent means ± SEM. *p < 0.05.OCN’s role in memory. OCN seems to act both in the DG, a re-
gion required to separate two similar memories with very distinct
differences, and in the CA3, which helps to retrieve a memory
when partial cues are presented (Besnard and Sahay, 2016).
We therefore first subjected cohorts of ST and DTmice to a novel
object recognition (NOR) task, which is a hippocampal-depen-
dent memory task (Clark et al., 2000; Pavlopoulos et al., 2013).
Administration of OCN (Figures 3A andS3A, bottom) or PBS (Fig-
ure 3A and S3A, top) in the DG (Figure 3A) or in CA3a (Figure S3A)
had no effect on the total exploration time between the familiar
and the novel phase in both DT and ST mice (Figures 3B and
S3B). However, the discrimination index of ST animals injected
with OCN in either hippocampal region was increased in the
novel phase of the task (Figures 3C and S3C). OCN administra-
tion either in the DG or in CA3a of DT animals failed to rescue the
deficit caused by inhibition of RbAp48 (Figures 3C and S3C),
demonstrating once again that inhibiting RbAp48 function in
young animals is important for spatial memory, and that OCN
signaling is blocked upon RbAp48 inhibition.962 Cell Reports 25, 959–973, October 23, 2018Since memory deficits can be associated with impairments in
pattern separation (Dillon et al., 2017; Holden and Gilbert, 2012),
the same groups of animals were further tested in a contextual
fear discrimination paradigm commonly used to assess pattern
separation (Jinde et al., 2012; Sahay et al., 2011) (Figure 3D).
OCN injection in the DG greatly increased discrimination in
ST animals but had no effect in DT animals (Figures 3E–3H). In
addition, we found that OCN had no effect in the same contex-
tual fear discrimination task when delivered into the CA3a region
(Figures S3D–S3G). ST animals injected with OCN in the DG
were able to discriminate better than those injected with PBS
or compared to DT animals injected either with PBS or OCN,
even 10 days after the end of the behavioral assay (Figure 3I).
In contrast, cohorts injected in CA3a did not display significant
differences (Figure S3H), demonstrating that OCN can mediate
differential effects in spatial and discrimination memory tasks
depending on the hippocampal region that it binds to.
Inability of OCN to produce a significant improvement in the
NOR task and in contextual fear discrimination paradigms
Figure 3. OCN Function Is Blocked by RbAp48 Inhibition
(A) Images of the DG showing accurate targeting of OCN (100 ng) 15 min after injection of mStrawberry alone (top) or fusion mStrawberry-OCN (bottom). Total
OCN (green) staining was performed as control (scale bar, 100 mm).
(legend continued on next page)
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when injected in the DG or CA3 of DT mice further suggests that
RbAp48 protein is necessary for OCN signaling, and that the
memory deficits observed in DT mice can be attributed to the
deregulation of the OCN/GPR158/BDNF pathway.
Knockdown of GPR158 in the DG Affects the Levels of
RbAp48 Protein and Discrimination Memory
We next wondered whether OCN/GPR158 signaling mediates
a loop that controls RbAp48 protein, which then regulates
GPR158 expression. We confirmed that endogenous OCN pro-
tein co-localizes with GPR158 in the DG and CA3 (Figure S4A)
and further verified the interaction between GPR158 and OCN
in vitro. We tagged several variants of OCN with mStrawberry
(mStrawberry-OCN), and GPR158 with GFP (GFP-GPR158).
Overexpression of GFP-GPR158 in HEK293FT cells co-localized
with exogenously added fluorescent-tagged wild-type (WT)
mStrawberry-OCN (Figure S4B) and produced a dose-depen-
dent response with fluorescence resonance energy transfer
(FRET) (Figure S4C). GFP alone or mStrawberry alone were not
able to produce significant FRET (data not shown). In addition,
we performed a competitive binding experiment based on the
displacement of the interaction between His-tagged unlabeled
OCN and GFP-GPR158 with the mStrawberry-OCN. To produce
significant FRET signal, mStrawberry-OCN was required in
40-fold higher amounts (10 ng versus 0.25 ng), presumably to
displace the unlabeled bound OCN (Figure S4D). To further
explore the specificity of OCN for GPR158, we used fluorescent
forms of OCN with point mutations at the glutamate residue 13,
which partially mimics the carboxylation states (calcium binding
sites) of OCN (E13Q and E13F). Mutant OCN produced signifi-
cantly less FRET, compared with WT OCN (Figure S4E),
indicating that the observed response was specific to GPR158-
GFP/mStrawberry-OCN.
We then injected knockdown of GPR158 (shGPR158) and
control (shGFP) lentiviral particles into the DG and observed a
50% reduction in the protein levels of GPR158 expressed in
this region. Immunostaining for GPR158 revealed a similar
decrease in the protein levels of GPR158 and OCN (Figure S4G)
particularly in the granule cell layer but not in the hilus of the DG.
We also found a concomitant reduction in the protein levels of
RbAp48 (Figures 4A–4C), corroborating our finding that OCN/
GPR158 signaling mediates the upregulation of RbAp48.
Wenext investigatedwhether knockdownofGPR158 in theDG
could exert a behavioral change similar to the one observed upon
inhibition of RbAp48 in forebrain neurons. We therefore per-
formed the same behavioral tests as we did above (Figures 3
and S3). We found that knockdown of GPR158 in the DG pro-(B and C) Novel object recognition (NOR) test after injection of PBS or OCN in the
total exploration time between the familiarization and the testing phase (three-way
OCN had an effect only on ST mice compared to DT OCN-treated mice (two-way
versus DT; post hoc Bonferroni, p < 0.0001).
(D) Schematic contextual fear discrimination task.
(E–H) Contextual fear discrimination in ST or DT mice injected with OCN in the D
contexts after PBS injection (E and G), but only ST were able to discriminate the tw
three-way RM ANOVA, post hoc Bonferroni for treatment 3 contexts in ST mice
(I) Discrimination index of ST and DTmice injected in the DGwith OCN or PBS 10 d
still able to discriminate better than the ST PBS or DT OCN mice (one-way ANO
All data represent means ± SEM. *p < 0.05, **p<0.01, ***p < 0.001.
964 Cell Reports 25, 959–973, October 23, 2018duced a lower discrimination ability in a NOR assay, compared
with the functional control group (shGFP) (Figures 4D and 4E).
Similarly, mice with reduced levels of GPR158 in the DG
(shGPR158) showed a reduced discrimination ability by day 7
of a contextual fear discrimination behavioral task compared to
control animals (Figures 4F–4H). At day 7, we administered
OCN systemically in both groups via tail injection to exclude
the possibility that OCN signaling in other brain regions, and
particularly in CA3, is not compensating for the deficits observed
in the discrimination memory task. Control (shGFP) animals
showed an increase in their discrimination ability until day 14,
whereas GPR158 knockdown animals (shGPR158) displayed a
significant deficit even with OCN administration (Figures 4F
and 4G). Ten days after the end of the experiment (day 24),
mice were re-exposed to the same two contexts and their
discrimination ability was assessed. Although shGPR158-
injected animals were able to discriminate between the two
contexts to some extent, they underperformed compared to
controls (Figure 4I). The overall reduced discrimination ability
upon knockdown of GPR158 is likely to be due to the reduction
in the protein levels of RbAp48 and to the failure of OCN binding
in the DG. These results are similar to what was observed in
DT mice upon OCN administration particularly in the DG.
OCN/GPR158 Signaling Controls Pre-exposure-
Mediated Contextual Fear Conditioning
Although tail vein administration of recombinant OCN was inef-
fective during contextual fear discrimination when GPR158
expression was knocked down in the DG/CA3c regions (Fig-
ure 4G), the discrimination ability of this control group (Figure 4F)
was different than that of the shGFP group, which received direct
administration of OCN in the DG (Figure 3F). We therefore
wondered whether OCN binding in the CA3, a sub-region
responsible for pattern completion, may explain the reduced
discrimination ability of the tail-injected control mice.
To test whether tail vein administration of OCN can bind to the
DG and to CA3, we injected purified, recombinant His-tagged,
OCN to WTmice via the tail vein and found that in the hippocam-
pus the recombinant hormone, along with the endogenous form,
binds mostly to CA3 and some to the DG (Figure S5A).
Usinga three-foot-shockcontextual fear conditioningparadigm
(Figure S5B), we sought to determinewhether tail vein administra-
tion ofOCNwasable to influence freezing levels upon exposure to
a shock-associated context versus exposure to a novel context
not associated with shock. OCN- and PBS-injected control mice
showed similar freezing levels when re-exposed to the same
context (A) 24 or 48 hr after fear conditioning (Figures S5C–S5E).DG of ST and DTmice (n = 16 mice per group). No differences were detected in
ANOVA, post hoc Bonferroni) (B), and discrimination index for novel object (C).
repeated-measures [RM] ANOVA comparisons between OCN or PBS and ST
G/CA3c (F and H). Both genotypes were able to discriminate between the two
o contexts after OCN injection (F) (two-way RM ANOVA, post hoc Bonferroni;
, p = 0.0003, and treatment 3 contexts in DT mice; n = 16 mice per group).
ays after the end of contextual fear discrimination. OCN-injected STmice were
VA, post hoc Bonferroni, p = 0.0029 and p = 0.0194).
Figure 4. GPR158 Knockdown in the DG Decreases RbAp48 Levels and Impairs Discrimination Memory
(A) Quantification of RbAp48protein fromdissectedDGafter injection of shGFP (control) or shGPR158 (knockdown) (unpaired t test, p = 0.0005; n = 4–5micepergroup).
(B) Images of shGFP-injected (control, top) or shGPR158-injected (knockdown, bottom) DG stained for RbAp48 (red) and GFP (green) (scale bar, 200 mm).
(C) Knockdown with shGPR158 results in decreased RbAp48 expression in the DG when compared with shGFP control mice (unpaired t test, p < 0.0001) (n = 4
mice per group).
(D) No differences were detected in total exploration time between the familiarization and the testing phase after injections of shGFP or shGPR158 viruses in the DG.
(E) Discrimination index for novel object during a NOR test. shGFPmice were able to discriminate the novel object better than shGPR158-injected mice (two-way
RM ANOVA comparisons, post hoc Bonferroni; n = 20 mice; p = 0.0193) (Fam versus Nov shGFP, p < 0.0001, and shGPR158, p = 0.0061).
(F and G) Contextual fear discrimination in mice injected with shGFP (F) or shGPR158 (G) in the DG (three-way RM ANOVA comparisons of treatment3 contexts
in shGFP versus shGPR158 mice, post hoc Bonferroni, p = 0.0158).
(legend continued on next page)
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However,OCN-injectedmice froze significantly less than the con-
trols when introduced to a similar context (B) that was novel (Fig-
ure S5F), suggesting that OCN administration might be able to
either decrease generalization or increase discrimination between
twosimilar but different contexts processes, both ofwhich involve
the hippocampal formation.
Because CA3 region is responsible for pattern completion
(McHugh et al., 2007; Nakashiba et al., 2009), we investigated
the potential role of OCN binding in this region (Khrimian et al.,
2017) using a pre-exposure contextual fear conditioning task (Na-
kashiba et al., 2012) (Figure 5A). We hypothesized that binding of
OCN inCA3might account for the reducedperformanceof control
mice with OCN tail administration. Different cohorts of young WT
mice were pre-exposed to a specific context D for 10 min per
day for 5 consecutive days (Figure S5G). On the sixth day, they
received a strong foot-shock for 2 s and remained in the chamber
for an additional 30 s (Figure 5B). 24 hr later, they received injec-
tions of either OCN or PBS into the CA3a region, and 48 hr after
administration they were re-exposed to the same context (D).
OCN-injected mice showed significantly higher freezing than the
PBS-injected group, indicating enhanced pre-exposure-medi-
ated contextual fear conditioning (Figure 5C).
In contrast, when OCN or PBS was injected into the CA3a re-
gion of DT or STmice, there was an increase in the freezing levels
on pre-exposure-mediated contextual fear conditioning only in
the ST animals injected with OCN (Figures 5D and 5E). No signif-
icant differencewas observed uponOCNadministration inDT an-
imals or in PBS injected ST or DT animals (Figures 5D and 5E).We
also found no significant difference between the groups upon the
5-day pre-exposure (Figure S5H). These results confirm that OCN
signaling is dispensable upon inhibition of RbAp48 also in the
CA3a hippocampal region and can potentially explain the inability
of OCN to affect contextual fear discrimination memory when in-
jected in the CA3a hippocampal sub-region.
Finally, to investigate whether OCN binding in the CA3a region
interferes with contextual fear discrimination memory, we
knocked down GPR158 in the DG and subjected the two
cohorts (shGPR158 and shGFP) in a pre-exposure-mediated
contextual fear conditioning paradigm. We found no significant
differences between the two groups upon the 5-day pre-
exposure (Figure S5I) or during the shock phase (Figure 5F).
We then administered OCN via the tail vein in both groups and
re-exposed them 48 hr later to context D. Mice with GPR158
knockdown in the DG showed increased freezing levels
compared to shGFP controls (Figure 5G), presumably because
of preferential binding of OCN to CA3a rather than the DG/
CA3c hippocampal regions. Seven days after the end of the
behavioral task, both groupswere sacrificed and stained for total
OCN. Mice injected with shGPR158 in the DG (Figure S5J) had
more OCN accumulated in the CA3a region than mice injected
with shGFP (Figures 5H, 5I, and S5K). Taken together, these
data show that OCN/GPR158/RbAp48 signaling pathway can
differentially affect fear discrimination memory in the hippocam-
pal formation.(H and I) Discrimination indexes between shGFP and shGPR158 at day 7 (H) and
day 24; n = 16 mice).
All data represent means ± SEM. *p < 0.05, **p<0.01, ***p < 0.001.
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To date, several cell types of the hippocampus have been impli-
cated in contextual fear discrimination, with particular emphasis
on neuronal progenitor cells and their lineage (Drew et al., 2010;
Jinde et al., 2012; Sahay et al., 2011). So far, we have demon-
strated that forebrain-specific inhibition of RbAp48 and decrease
of RbAp48 protein levels through viral knockdown of GPR158 in
theDGcandisrupt contextual feardiscrimination. Tobetter under-
stand the relationship of OCN, GPR158, and contextual fear
discrimination, we used a transgenic mouse line NestinCreERT2/
Rosa26/E-YFP (Dranovsky et al., 2011) in combination with
pSico/pSicoR CRE/LoxP lentiviral vector system (Ventura et al.,
2004). Using this viral system (Figure 6A), we were able to restrict
GPR158deletion toasubsetofneuralprogenitorcellswhen inject-
ing pSico-shGPR158 (termed Nestin+), or we could restrict
GPR158 knockdown to non-Nestin-positive cells (termed
Nestin), by injecting pSicoR-shGPR158 virus (Figure 6A).
We showed that the GPR158 knockdown reduced RbAp48
levels in Nestin+ and Nestin cells (Figures 6B and S6A–S6C),
and that this effect was dependent on the tamoxifen treatment,
particularly in Nestin+ cells (Figures S6D and S6E). Ten days after
virus injection, we subjected the three groups of mice to a NOR
task. Although control and Nestin mice displayed reduced
exploration times between the familiar and novel phases, there
were no significant differences between the control (shGFP)
mice and the Nestin+ or Nestin groups in the total exploration
times during the familiar or the novel phase (Figure 6C). However,
control mice discriminated the novel object better compared to
the groups of mice in which GPR158 was knocked down in
Nestin+ or Nestin cells (Figure 6D).
We then subjected the same groups of mice to a contextual
fear discrimination behavioral task. Control mice (shGFP) were
able to discriminate between the contexts A (shock) versus
context B (no shock) compared to GPR158 knockdown in the
Nestin+ or Nestin (Figures 6E–6G). This deficit in GPR158
knockdown in Nestin+ or Nestin cells was still detectable
even 10 days after the end of the task (Figure 6H). Taken
together, these data indicate that knockdown of GPR158 directly
affects the function of RbAp48 also in non-neuronal progenitor
cell types, leading to discrimination memory deficits similar to
those observed in DT mice with or without OCN administration.
OCN Administration Ameliorates Age-Related Memory
Loss and Increases RbAp48
Our data were indicative that OCN/GPR158 signaling controls
RbAp48 protein and affects discrimination memory. Since we
have previously found an involvement of both RbAp48 and
OCN proteins in age-related memory loss (Khrimian et al.,
2017; Pavlopoulos et al., 2013), we wondered whether activation
of OCN/GPR158 pathway can elevate RbAp48 levels in middle-
aged animals and rescue any age-associated deficits in discrim-
ination memory. We administered OCN or PBS into the DG of
16-month-old mice and found that OCN upregulated the proteinday 24 (I) (unpaired t test, p = 0.0224, day 7; and unpaired t test, p = 0.0232,
(legend on next page)
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levels of RbAp48 along with CBP and BDNF protein levels within
48-hr administration (Figures 7A–7E and S7A). Furthermore,
OCN administration in the aged DG was able to improve NOR
memory (Figures 7F and 7G) and restore the discrimination
ability in 16-month-old mice, compared to PBS-injected controls
(Figures 7H and 7I). Ten days after the end of these tasks,
16-month-old, OCN-injected mice displayed improved contex-
tual fear discrimination when compared with age-matched
control PBS-injected mice (Figure 7J).
Consistent with our observation in young animals, injection of
OCN into theCA3a regionof 16-month-old animals also increased
their ability to discriminate between a familiar and a novel object
(Figures S7B and S7C). When the same animals were subjected
to a contextual fear discrimination task, they increased their ability
to discriminate between the two contexts; however, OCN admin-
istration in the CA3a region could not enhance the discrimination
ability of 16-month-old animals compared to PBS-injected con-
trols (Figures S7D andS7E). Ten days after the end of these tasks,
16-month-old, OCN-injected mice in CA3a displayed similar
contextual fear discrimination when comparedwith age-matched
PBS-injected mice (Figure S7F).
It is well established in humans and in rodents that hyperactivity
in CA3 is an index of network dysfunction in age-related
memory loss (Leal and Yassa, 2015). We therefore thought that
OCN injection in the CA3a region should not be effective in a
pre-exposure-mediated contextual fear conditioning paradigm
as described earlier. We trained middle-aged (16-month-old)
mice in the same pre-exposure contextual fear conditioning para-
digm (Figure S7G). OCN administration had a small effect in aged
animals on the first minute of exposure but not in the overall
freezing levels (Figures 7K and 7L). These results further confirm
the differential effects of OCNon aging in the DG andCA3 regions
and demonstrate that RbAp48 regulation in the DG is essential for
discrimination memory in young and aged mice.
DISCUSSION
Molecular Consequences of RbAp48 Function in the
Hippocampus
In an effort to delineate the DNA targets of RbAp48, we found that
RbAp48 binds to the GPR158 locus, a GPCR that mediates pro-
cognitive effects of the bone-derived hormone OCN. Our data
demonstrate that RbAp48 protein binds to the GPR158 genetic lo-Figure 5. OCN/GPR158 Signaling in the CA3a Affects Pre-exposure-M
(A) Schematic of pre-exposure contextual fear conditioning.
(B) Freezing levels of mice injected with PBS or OCN 30 s after one 1.5-mA foot-
(C) Freezing levels during 1–3 min of exposure to context D 48 hr after injection of
RM ANOVA, post hoc Bonferroni; n = 10 mice per group; p = 0.0311 and p = 0.0
(D) Freezing levels of ST and DT mice injected with OCN or PBS in CA3a 30 s af
(E) Freezing levels of ST and DTmice 1–3min during exposure to context D 48 hr af
RM ANOVA for OCN versus PBS, Bonferroni post hoc, p = 0.0136 and p = 0.0295
mice; three-way ANOVA for genotype 3 treatment effect, p = 0.0094; n = 12 mic
(F) Freezing levels of shGFP and shGPR158 mice injected in DG/CA3c 30 s after
(G) Freezing levels of shGFP and shGPR158 mice in DG/CA3c during exposure to
mice had an increase in freezing (two-way RM ANOVA, post hoc Bonferroni; trea
(H) Images from CA3a regions of shGFP (control, top) or shGPR158 (knockdown,
pre-exposure-mediated contextual fear conditioning, stained for GFP (green) an
(I) Quantification of OCN protein accumulation in the CA3a region 7 days after the
All data represent means ± SEM.
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Although injection of OCN in the DG of ST or DT animals failed to
produce a significant change in GPR158 mRNA levels after 24 hr,
it is possible that GPR158mRNA becomes transiently upregulated
at earlier time points. It should also be considered that different
amounts of OCN might be required by the different cell types in
the DG to produce changes in the levels of GPR158mRNA (Sutton
et al., 2018). Alternatively, GPR158 could be modulated at a post-
transcriptional level to balance OCN function (Li et al., 2018) sec-
ondary to regulationofadifferent locusbyRbAp48.Thus,decipher-
ing the molecular regulation of OCN/GPR158/RbAp48 signaling is
an avenue for further studies. A recent study found that knockdown
of RbAp48 protein in T98G cells causes suppression of GPR158
mRNA (Kitange et al., 2016). Our results provide an examplewhere
this molecular regulatory pathway governs normal brain function.
We also found that RbAp48 controls BDNF mRNA levels,
another critical component of OCN/GPR158 signaling pathway
(Khrimian et al., 2017). In addition, OCN administration affects
both protein andmRNA levels of RbAp48 in the DG. These results
favor the possibility that OCN/GPR158 signaling creates a loop
involving RbAp48 and BDNF proteins. Given the fact that
RbAp48 is a member of several chromatin complexes (Henriquez
et al., 2013; Muralidharan et al., 2017), involved in transcriptional
activation and repression, we believe that the transcriptional
regulation of GPR158 locus by these complexes can regulate
the availability of OCN and GPR158 in hippocampal sub-regions,
mediating its beneficial effects in cognition and aging.
RbAp48 Involvement in Discrimination Memory
Normal aging may produce deficits in memory for NOR (Broad-
bent et al., 2009; Grady et al., 1995; Resnick et al., 1995) and for
pattern separation/completion processes (Clark et al., 2017;
McAvoy et al., 2016). To correlate our molecular findings with
these mnemonic processes, we used a variety of behavioral
tasks with high interference in mice, which presumably mimic
behaviorally the pattern separation/completion processes in
humans. Our results show that OCN administration to either
the DG/CA3c or CA3a enhance NOR memory, whereas the
OCN beneficial effects in a contextual fear discrimination para-
digm are limited to the DG/CA3c regions of young and middle-
aged mice. These effects are completely abolished when the
RbAp48 function is inhibited in the DG or when RbAp48 levels
deteriorate during natural processes such as aging.ediated Contextual Fear Conditioning
shock.
OCN or PBS in CA3a. OCN enhances freezing after injection in CA3a (two-way
013).
ter one 1.5-mA foot-shock.
ter injection of OCNor PBS in CA3. OCN had an effect only in STmice (two-way
for first minute and second minute comparison between ST OCN and ST PBS
e).
one 1.5-mA foot-shock.
context D, 48 hr after tail injection of OCN. Tail injection of OCN in shGPR158
tment, p = 0.0409; n = 11 mice per group; p = 0.0228 for first minute).
bottom) animals injected in the DG after peripheral administration of OCN and
d OCN (red) (scale bar, 20 mm).
end of the behavioral task (unpaired t test, p = 0.0397; n = 6 mice per group).
(legend on next page)
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Wealso observe similar effectswhenGPR158 is knockeddown
in the DG/CA3c region, which in turn reduces the RbAp48 protein
levels. We demonstrate that GPR158/OCN/RbAp48 function is
essential mainly in the granule neurons of the DG and may play
a similar role in the immature neurons of adult mice (Oury et al.,
2013). Consistent with other studies (Arruda-Carvalho et al.,
2014; Sahay et al., 2011), our results show that inhibition of
OCN/GPR158/ RbAp48 loop in neuronal progenitor cell types
(Nestin+) and in thegranulecell typesof theDG(Nestin) canaffect
contextual fear discriminationmemory. Alternatively, cells outside
the neuronal lineage (e.g., parvalbumin) could exert additional
control in Nestin cells (Bao et al., 2017).
In addition, we found that OCN has a different role in a behav-
ioral pattern completion task when administered in the CA3a
region, where it enhances pre-exposure-mediated fear condi-
tioning only in young animals. This enhancing effect is abolished
upon inhibition of RbAp48 and more importantly is enhanced
only upon peripheral OCN administration in the CA3a region
when the GPR158 protein levels are knocked down in the DG.
The above data highlight at the molecular level the importance
of circuit integrity between the DG and the CA3 hippocampal
sub-regions in pattern separation/completion processes.
This investigation provides more direct evidence for the central
role of RbAp48 in age-related memory loss. Our results corrobo-
rate the connection between blood circulating factors and normal
brain function (Castellanoetal., 2017;Villedaetal., 2014) andshow
that deterioration of humoral factors outside the brain can poten-
tially lead to abnormal neuronal function (Khrimian et al., 2017;
Oury et al., 2013).We further show that one of these blood-derived
factors, OCN, controls RbAp48 via GPR158 and that in turn exerts
regulation in the GPR158/BDNF proteins and probably OCN.
Taken together, these results show that RbAp48 function is indis-
pensable to NOR memory and to memory discrimination tasks,
including behavioral pattern discrimination and completion. This
is interestingbecause itprovides thefirstexampleofanucleosome
remodeling factor involved in histone acetylation that is directly
associated with these behavioral processes.
On the circuit level, OCN’s regulation of RbAp48 protein may
also act as a modulator of the mnemonic processes. Binding
of OCN in the DG seems to enhance the ability of the hippocam-
pal formation to enhance discrimination between memories,
whereas binding in the CA3a helps to retrieve a memory when
partial cues are presented. Both of these processes were atten-Figure 6. Disruption of OCN/GPR158 Signaling in Nestin+ and Nestin
(A) Schematic of viral strategy to disrupt GPR158/OCN signaling in Nestin+ and N
(B) Images of DG from control and GPR158 knockdown mice, in Nestin+ or Nes
GPR158 (red) (scale bar, 100 mm).
(C) shGFP and Nestin mice spent less time exploring both objects in the nove
Bonferroni; n = 9 mice per genotype; p = 0.001, Fam versus Nov, p = 0.001 for s
genotypes in total exploration time in the familiarization or the testing phase.
(D) Discrimination index for novel object during a NOR test in control (shGFP) and
discriminate the novel object (two-way RM ANOVA comparisons, post hoc Bonf
(E–G) Contextual fear discrimination in control (shGFP) (E) and Nestin+ (F) or N
between contexts (two-way RM ANOVA comparisons of treatment 3 contexts b
post hoc Bonferroni, p < 0.0001).
(H) Discrimination index of control (shGFP) and Nestin+ or Nestin GPR158 knoc
shGFP mice were able to discriminate between the two contexts (one-way ANO
All data represent means ± SEM. *p < 0.05, **p<0.01, ***p < 0.001.
970 Cell Reports 25, 959–973, October 23, 2018uated when RbAp48 function is inhibited. This is further sup-
ported by the fact that OCN administration in the agedCA3a pro-
duces a minor effect in a behavioral pattern completion task
highlighting that age-related memory loss might be a combined
defect of both decreased discrimination and increased general-
ization (Besnard and Sahay, 2016). It is therefore of particular in-
terest and importance that this phenomenon is also observed in
aged humans (Yassa et al., 2011).
Furthermore, since OCN increases RbAp48 and BDNF mRNA
levels and produces an activity-dependent effect on the synap-
ses of the outer molecular layer of the DG (Figure 2D), we believe
that upregulation of RbAp48 in the aging DG potentially activates
a transcriptional program potentially leading to enhance synapse
maintenance. This notion is consistent with our behavioral re-
sults and also with the fact that knockdown of RbAp48 protein,
as a part of NuRD complex, decreases the maturation of granule
neurons and their incorporation into the cerebral circuits
(Yamada et al., 2014).
Finally, our results suggest that any therapeutic intervention
regarding age-related memory loss needs to be studied exten-
sively on several mnemonic processes to understand the impact
of these interventions on the neuronal circuitry.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
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(C) Images of the DG from 16-month-old WT mice stained for CBP (green) and BDNF (red), 48 hr after injection of PBS (20 ng) (top) or OCN (bottom) (scale bar,
100 mm).
(D and E) Quantification of CBP (D) and BDNF (E) protein levels after injection of OCN or PBS in the DG of 16-month-old WTmice. OCN increases CBP and BDNF
levels (unpaired t tests, p < 0.0001 and p = 0.034, respectively; n = 6 mice per group).
(F) No differences were observed between the genotypes in total exploration time in the familiarization or the testing phase.
(G) Discrimination index for novel object after injections of PBS or OCN in the DG of 16-month-old WT mice (two-way RM ANOVA comparisons, post hoc
Bonferroni, n = 16mice per group treatment, p = 0.0036, Fam versus Nov, p = 0.0008). Agedmice injected with OCN in the DGwere able to discriminate between
the novel and familiar object.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Mice were maintained under standard conditions approved by the IACUC. All WT mice c57/BL6 were purchased from Jackson
Laboratories (RRID:IMSR_JAX:000664). 16-month-old mice (c57/BL6) were purchased from Taconic (RRID:IMSR_TAC:b6) at
12 months of age and used at 16 months old. The tetO–Flag RbAp48-DN mice (backcrossed more than 10 times to C57BL/6J
background) were bred with CaMKIIa-tTA mice (backcrossed more than 10 times to 129SvEvTac background) as described
previously (Pavlopoulos et al., 2013). For regulating tetO-driven gene expression, mice were fed chow supplemented with
doxycycline (40 mg/kg) (Mutual Pharmaceutical) as previously described (Pavlopoulos et al., 2011). c-Fos-CreERT2 (Luo)
(RRID:IMSR_JAX:021882) was bred with tdTomato (Ai14) (RRID:IMSR_JAX:007914) and both lines were purchased from
Jackson Laboratories. NestinCreERT2/Rosa26/EYFP was a generous gift from Dr. Alex Dranovsky (Dranovsky et al., 2011). Male
and female mice were used for all behavioral and experimental testing. All experiments involving animals were approved by the
Institutional Animal Care and Use Committee of Columbia University Medical Center.
Neuronal Cultures
Neuronal cultures were prepared from P0 pups according to Beaudoin et al. (Beaudoin et al., 2012).Cell Reports 25, 959–973.e1–e6, October 23, 2018 e2
HEK293FT cell culture
HEK293FT were purchased from Life Sciences and cultured according to manufacturer’s instructions (RRID:CVCL_6911).
Production of OCN and E13Q and E13F
WT and mutant Osteocalcin (OCN) were produced in E. coli (C2566, T7 express competent cells, NEB C2566I). Briefly, the trans-
formed cells were grown on a shaker at 37C until OD600 was measured to be 0.8, after which they were induced with 1mm
IPTG for 4 hours.
METHOD DETAILS
Stereotaxic Injections
Stereotaxic injections were performed as described previously (Pavlopoulos et al., 2013). Mice were anaesthetized with a Ketamine/
Xylazine mixture (100mg/ml/kg) and (20mg/ml/kg) respectively. Injections were targeted bilaterally to the DG (dentate mainly
and CA3c) (1.96 mm anteroposterior (AP), ± 1.28 mm mediolateral (ML), 1.98 mm dorsoventral (DV)), CA3 (1.96 mm AP, ±
1.8 mm ML, 2.0 mm DV) (CA3a mainly and CA3b). Injection volumes ranged from 0.5 to 1 mL and contained 5ng of purified
OCN. This amount was used for mice in all behavior experiments unless otherwise stated in the figure legends. Injection time was
10min. After the injection the needle remained in place for another 10 min before it was withdrawn.
Tamoxifen (TAM)
NestinCreERT2/Rosa26/EYFP animals aged 8–12 weeks were administered 5 mg of tamoxifen (Sigma), suspended in 100 mL 1:1
honey:water mixture by gavage once a day for 4 days, at least 12 hr apart according to Dranovsky et al. (Dranovsky et al., 2011)
and handled for at least 3 min each day. Immediately after the last dose of tamoxifen (1-3 days) all the animals were injected in
the DG with pSico/pSicoR GPR158 or shGFP viral particles. Ten days later all groups were subjected to further experimental
manipulations as described below. c-Fos-CreERT2/tdTomato received 2 doses of 5 mg Tamoxifen prior to any other experimental
manipulations.
Tail Vein Injections
Mice were restrained in a plastic chamber with ample ventilation for less than 30 s in order to receive tail injections. All mice prior to
behavioral analyses were habituated to the restrain process for at least five days before the experiments in order tominimize stress to
this procedure. Successful tail vein injections were verified by injecting 100 mL of 0.9% Evans blue in NaCl.
ChIP (Chromatin Immuno-Precipitation)
For ChIP assays LowCell ChIP kit (C01010071 Diagenode) was used according to manufacturer instructions. Because RbAp48
protein does not bind directly to DNA we used dual crosslinking with 1.5 mM EGS (Invitrogen). For DNA isolation the iPURE v2
(C03010015 Diagenode) kit was used according to manufacturer instructions. Fold enrichment was calculated using the 2-DDCt
method.
Behavior
All mice were under constant environmental enrichment and were handled for 3-5 days for at least 3 min before the beginning of the
behavioral tasks. Male and female mice were used for all behavioral testing. After handling at Day 1 mice were injected with
Osteocalcin or (PBS) control. After 3 days of recovery mice were tested in an elevated plus maze task. Next all the cohorts were
exposed to an empty arena followed by exposure to identical objects (familiar phase) and 24 hours later to a familiar and a novel
object (novel phase). 24 hours later mice were exposed to context C and one day later they were first exposed to neutral context
B and then to context A (shock) for fourteen consecutive days. Ten days after the end of the task (Day24) groups of mice were
re-exposed to both contexts without any shock.
Mice injectedwith Lenti-viruses were left without any behavioral manipulation10-21 days before subjected to the same battery of
behavioral tasks. Different cohorts of mice were used for the pre-exposure mediated contextual fear conditioning.
Elevated Plus Maze (EPM)
To exclude any anxiety related effects each cohort of mice was first subjected to an elevated plus maze task (Table S3, detailed
Elevated Plus Maze data related to Figures 3, 4, 6, 7, S3, and S7). Mice were tested in an elevated plus maze (EPM). Mice were
placed in the testing room one hour prior to testing. Mice were then placed in the center of an elevated plus maze (arm length across,
60x60cm) with a set of open arms and a set of closed arms and allowed to freely explore the maze for 6 minutes before being
removed and placed back in their home cage. Videos were recorded using Ethovision software and were additionally scored
manually with experimenter blind to the treatments. Measurements were scored based on the location of the mouse (center,
open arm, closed arm).e3 Cell Reports 25, 959–973.e1–e6, October 23, 2018
NOR
NOR assay was performed as previously described (Pavlopoulos et al., 2013) with minor modifications. Briefly, mice were left to
explore an empty rectangular arena (45 3 45 cm) with visual cues the first day for 6 min. The following day mice were presented
with 2 identical objects (2 rectangular black boxes) (familiar phase) and time spent with each object was recorded using Ethovision
software. 24 hours after, mice were put back in the same arena with a novel object (white cylinder) and a familiar one for 6 min (novel
phase). Videos were additionally scored manually with experimenter blind to the treatments. Discrimination index was calculated
measuring the amount of time spend with novel object minus the amount of time spend with familiar versus the total exploration
time for both objects. Total exploration time was used as a control measurement in each phase to ensure that any observed differ-
ence is not due to anxiety or hyperactivity of the tested subjects. Discrimination index was calculated as: time spent with the first
object minus time spent with the second objected, divided by the sum of time spent with both objects.
One Trial Contextual Fear Discrimination learning (Pattern separation)
Pattern separation was performed as previously described with minor modifications (Sahay et al., 2011). Med Associates Fear con-
ditioning chambers were used. The shock associated training Context A had features including an empty chamber with an exposed
floor grid, light and fan on, inner and outer chamber doors completely closed, and the mouse placed in the chamber oriented away
from the door. The no-shock Context B was the same chamber with a white plastic insert covering the floor grid, a black triangle
shaped insert above the floor, a mild lemon scent (0.4% v/v lemon extract in water), inner and outer doors slightly ajar, light and
fan off, and the mouse was placed in the chamber oriented toward the door. One day prior to the experiment mice were exposed
for 3 min to a Context C which featured a white plastic insert covering the floor grid, a concave white insert covering the left, right,
and back walls, light and fan were off, inner and outer chamber doors were completely closed, and the mouse placed in the chamber
oriented away from the door. A non-alcoholic antiseptic was used to clean the chamber after each run in all conditions. Mice were
brought into the entry room next to the testing room and left there for an hour to acclimate before any testing. Mice were exposed for
3 min to the training context A in which they received a single 2 s foot shock of 0.75mA. 15 s after shock delivery mice were taken out
of the chamber and returned to their home cage and placed in the entry room. One hour later, mice were placed in the similar context
B in which they were left for 3min andwere never shocked. Measurement of freezing levels in both training context (threeminutes pre
shock) and in the similar context (three minutes) each day allowed assessment of discrimination between the two contexts and was
computed as a Discrimination index: (%Freezing context shock - %Freezing no shock)/ (%Freezing context shock + %Freezing no
shock). Freezing levels were automatically measured using Med Associates software.
Pre-exposure Contextual Fear Conditioning
Mice were pre-exposed to a Context D in which the chamber had an exposed grid, a concave white insert covering the left, right, and
back walls, and a peppermint scent (4% v/v extract in water). A non-alcoholic antiseptic was used to clean the chamber after each
run. Mice were placed in the chamber for 10 minutes for 5 consecutive days. On the sixth day they were placed in the chamber for
10 s, given a strong foot shock 1.5mA, and remained in the chamber an additional 30 s before being removed. 24 hours after this the
mice undergone surgery or received tail injections. 48 hours after, they were re-exposed to Context D for 3 minutes.
Contextual Fear Conditioning in c-Fos-CreERT2/tdTomato mice
Mice received 2 doses of tamoxifen orally prior to any behavioral manipulation. Two weeks later, mice were exposed for 4 min to the
training context A in which they received 3 foot shocks of 0.7 mA for 2 s, 1 min apart (Learning). Twenty-four hours later, mice were
injected with OCN or PBS in the DG. Seven days later animals were exposed to the same context without any shock and freezing
levels were measured with Med Associates software.
RNA Extraction and Gene expression analysis
DG were dissected as previously described (Hagihara et al., 2009), flash frozen and stored at 80C. RNA was extracted using the
RNA easy mini kit (QIAGEN) according to standard protocols. qPCR was performed on a C1000 Touch Real-Time PCR Detection
System (BioRad). Fold enrichment was calculated using the 2-DDCt method. All primer sequences are available upon reasonable
requests.
Site Directed mutagenesis and production of OCN and E13Q and E13F
ORF of Osteocalcin was a generous gift from Drs. Frank Ouri and Gerard Karsenty. cDNAwas amplified with the appropriate primers
and it was sub cloned to a pRSET expression vector (Invitrogen V35120). Mutant OCN was created using primers for site directed
mutagenesis with the Lightning kit (Agilent). WT and mutant Osteocalcin (OCN) were produced in E. coli (C2566, T7 express compe-
tent cells, NEBC2566I). Briefly, the transformed cells were grown until OD600wasmeasured to be 0.8, after which theywere induced
with 1mm IPTG for 4 hour. Cells were lysed with lysis buffer (50 mm Tris pH 7.65, 10% glycerol, 1M NaCl, 0.01% NP40 substitute,
10 mm Imidazole, with 100ug/ml lysozyme, 100ug/ml DNase, 100ug/ml RNase). The lysed solution was then centrifuged and the
supernatant was applied to a column containing Ni-NTA resin and allowed to rotate in suspension for one hour to allow for binding
of the protein. The protein was eluted with elution buffer (50 mm Tris pH 7.65, 10% glycerol, 1M NaCl, 0.01% NP40 substitute,
300 mm Imidazole). Protein purification was done using the QIAGEN Ni-NTA Fast Start Kit (30600). For Fluorescent tags of mutantCell Reports 25, 959–973.e1–e6, October 23, 2018 e4
and WT OCN the above ORF were cloned on the C-terminal end of the mStrawberry vector (Clontech 632530) in order to produce
mStrawberry wt OCN, E13Q and E13F. Proteins were produced and purified using the methods described above. Additionally
fluorescently tagged proteins were further purified using the mStrawberry isolation kit (ChromoTek, RFP-Trap_MA kit, rtmak-20)
according to manufacturer’s instructions.
GPR158 mouse ORF was purchased from DNASU and subcloned on the pAc-GFP1-N (Clontech 632485) and pAc-GFP1-C
vectors (Clontech 630458).
shRNA’s against the GFP protein or GPR158 were cloned in the pSICO (Addgene 11578) and pSICOR (Addgene 11579) vectors
according to standard procedures (Ventura et al., 2004). For pSICO mCherry shGPR158, GFP was substituted with the
mCherry ORF (pmCherry-N1 632523). Target sequences: for GFP: GCAAGCTGACCCTGAAGTTCAT and for GPR158:
GCTCATTATCACGGCTATATT.
HEK293FT cell culture, transfection, and production of Lentiviral particles
HEK293FT were purchased from Life Sciences and cultured according to manufacturer’s instructions (R700-07). For transfections
we used FuGENE 6 (Promega) transfection reagent according to manufacturer’s instructions. Viral particles were produced using
the HEK293FT cell line according to standard procedures in a BSL-2 safety cabinet. Briefly, T175 flasks were seeded with
2.0 3 107 cells on day 1 with HEK293FT cells. Twenty-four hours later and two hours before transfection, medium was replaced
in each flask with 15 mL of pre-warmed Optimem medium (Life Sciences). Transfection DNA was prepared by adding 18 mg of
the vector of interest, 9 mg of pMDLg/pRRE (Addgene 12251), 3.6 mg of pRSV-REV (Addgene 12253) and 5.6 mg of pCMV-VSV-G
(Addgene 8454) (Dull et al., 1998) in 3.9 mL Optimem. One hundred ul of Lipofectamine 2000 (Life Sciences) was added to 3.9 mL
of Optimem and incubated at room temperature for 5 min. Transfection DNA and Lipofectamine mix were combined in a
single tube and incubated for at room temperature for 20 min. Transfection mix was added to the plates and incubated for at
37C. Six hours later transfection mix was replaced by DMEM medium 1% FBS without antibiotics. 2-3 days after transfection
supernatants were concentrated via Ultracentrifugation. The viral titers were 109/ml.
Fluorescent binding assays with GPR158
For fluorescent binding between GPR158 and Osteocalcin we have used a FRET based assay according to Emami et al. (Emami-
Nemini et al., 2013). Briefly, we used HEK293 FT cells transiently transfected in 96 well black coated plates (CoSTAR) with N- or
C-terminal GPR158 GFP constructs. For each well of a coated 96-well plate we have used 30,000 HEK293FT cells per well, 50 mL
of medium and 60 ng of plasmid DNA. Cells were transfected in Optiprep solution using FuGENE 6 transfection reagent according
to manufacturer’s instructions. 12 hours after, the medium was changed with complete DMEMmedium and the cells were left in the
incubator for additional 24 hours. The following day the medium was discarded and replaced with assay buffer (20 mM HEPES,
100 mM NaCl, 3 mM MgCl2 and 0.2% (wt/vol) nonfat milk (pH 7.5) at 25C. Fluorescent recombinant proteins were added at the
indicated concentrations and incubated at 25C for 20 min. To measure the bound fluorescence signal the Clariostar reader was
used. An appropriate filter setup for FRET was used based on the GFP and mStrawberry fluorophores. Raw FRET was calculated
by dividing the amount of fluorescence transferred to GFP frommStrawberry with the amount of the GFP fluorescence. All described
experiments were performed multiple times. Single experiments with all the experimental conditions present are described in the
figures (n = 6-8 per condition). For competition assays using unlabeled OCN, cells were pre-incubated with the unlabeled ligand
(His-tagged Osteocalcin 0.25 ng/ul). 30 min later fluorescent proteins were added at the described concentrations.
ChIP-seq library preparation and analysis
Library preparations for ChIP-seq were carried out in the Greek Genome Center (GGC) of Biomedical Research Foundation of Acad-
emy of Athens (BRFAA) according to Illumina protocol (Ford et al., 2014). Single-end 75 bp reads were generated with NextSeq500 in
the GGC. Two independent ChIP and Input experiments were prepared for library construction. Libraries were filtered for low quality
reads and trimmed to 50 bp with the use of FASTX-Toolkit. Bowtie2 (Langmead et al., 2009) with –very-sensitive option was used for
aligning the data to the mm10 genome version and Samtools (version 0.1.19) (Li et al., 2009) were used for data filtering (rmdup) and
file format conversion. Both replicate ChIP and Input were merged in order to increase read depth and MACS14 algorithm (Zhang
et al., 2008) was used for peak calling with default settings. Data visualization was performed with IGV browser (Nicol et al., 2009)
while gene ontology and pathway analysis were performed with DAVID knowledgebase (Huang et al., 2009). Only pathways and
biological processes with p value% 0.05 were considered to be significantly enriched. ChIP-seq data have been deposited in the
Short Read Archive (SRA) under the accession codes SRP141688.
Western blot analysis
Mouse DG (2 per animal) were lysed in a mammalian extraction buffer (M-PER) (Thermoscientific) (150 ml) supplemented with and
Protease and Phosphatase inhibitor tablets (Roche). 10 to 20 mg of lysates were separated by SDS–polyacrylamide gel electropho-
resis in 4%–20% gradient gels (Biorad) and transferred to PVDF Fluorescent membranes (Millipore). Membranes were blocked with
Odyssey Blocking buffer. Membranes were cut in strips to detect multiple antigens according to the MW. Membranes were stripped
and reprobed for multiple antigen detection also, using stripping buffer from Thermoscientific. Immunoblots were analyzed with
the Odyssey Infrared Imaging System (LI-COR Biosciences). The whole hippocampus from 3- and 16-month-old animals wase5 Cell Reports 25, 959–973.e1–e6, October 23, 2018
used. 60 to 80 mg of total protein extracts were separated by SDS–polyacrylamide gel electrophoresis in 10%–20% Tricine gels
(Biorad). For Osteocalcin detection Supersignal Western Blot Enhancer kit was used (Thermoscientific 46640). Antibodies used:
Anti-RbAp48 antibodies (GeneTex Cat# GTX70232, RRID:AB_372869) and (Thermo Fisher Scientific Cat# PA1-869,
RRID:AB_2177636), Tubulin-1 (Sigma-Aldrich Cat# T7816, RRID:AB_261770), OCN antibody from Millipore (MABD123), BDNF
(Santa Cruz Biotechnology Cat# sc-546, RRID:AB_630940), CBP (Santa Cruz Biotechnology Cat# sc-7300, RRID:AB_626817)
and (Santa Cruz Biotechnology Cat# sc-583, RRID:AB_2245237), and GPR158 (GeneTex Cat# GTX87693, RRID:AB_10723755).
The image studio (Li-COR) was used for quantification.
Immunohistochemistry
Briefly, coronal sections (50 mm) along the entire rostrocaudal extension of the hippocampus were cut on a vibratome and stored in
0.1 M tris pH 7.4, 30% ethylene glycol, and 30% glycerol at 20C until further processed. Immunofluorescence was performed on
every fifth section. Sections were washed 3 times with 0.1M Tris pH 7.4, 0.15M NaCl and 0.3% Triton X-100 (TBSTX) at room tem-
perature. Antigen retrieval was performed at 80C for 30 min in 50mM Sodium Citrate buffer pH 8.8. Sections were additionally
washed 3 times with TBSTX buffer and blocked for 1 hour at room temperature in blocking buffer. (TBSTX supplement with mouse
IgG (1 mg/ml) and 1%BSA to reduce non-specific binding of mouse antibodies). Primary antibodies were incubated at 4C for 24 to
48h. After primary antibody incubation, sections were washed at least 3-5 times with TBSTX buffer and then were incubated with the
appropriate Alexa fluorescent secondary antibodies (Invitrogen). Sections were washed 3-5 times with TBSTX buffer and then
mounted on Superfrost slides (Fisher Scientific) with FluorSave Reagent (Calbiochem). Antibodies used: RbAp48 antibodies
(GeneTex Cat# GTX70232, RRID:AB_372869) and (Thermo Fisher Scientific Cat# PA1-869, RRID:AB_2177636), OCN antibodies
(Thermo Fisher Scientific Cat# PA1-85754, RRID:AB_2065062) and Millipore (MABD123), PSD95 (UC Davis/NIH NeuroMab Facility
Cat# 75-028, RRID:AB_2292909), anti-MAP2 (Abcam Cat# ab5392, RRID:AB_2138153), GPR158 (GeneTex Cat# GTX87693,
RRID:AB_10723755), anti-GFP from Abcam (Cat# ab13970, RRID:AB_300798) and Invitrogen (Molecular Probes Cat# A-11122,
RRID:AB_221569), anti-mCherry (Abcam Cat# ab205402, RRID:AB_2722769), BDNF Promega Cat#G1641, CBP/KAT3A Abcam
Cat#ab2832, and anti-parvalbumin (Swant Cat# GP72, RRID:AB_2665495). The secondary antibody against streptavidin was
the Streptavidin, Alexa Fluor 647 conjugate (Thermo Fisher Scientific Cat# S-21374, RRID:AB_2336066). For CIdU staining
antigen retrieval was performed for 30 min in 2N HCl (in PBS) at 37C and then the sections were washed with 0.1 M Boric Acid
at room temperature followed by three washes in TBSTX. Blocking was performed for 1 hour in 12.5% Normal Donkey serum
with 0.3% Triton X-100. Primary antibodies were diluted in the same solution.
QUANTIFICATION AND STATISTICAL ANALYSIS
Spine counting
Spine Counting was performed in the outer molecular layer (OML) of the DG according to Pavlopoulos et al. (2011) and McAvoy et al.
(2016).
DG Section Quantification
Between 5-8 brain sections (50 mm) were analyzed from each experimental animal. For each brain both hemispheres of the
hippocampus were analyzed. For RbAp48, the region of interest in each section was manually circled and the mean intensity of
the fluorescence of this area was measured using ImageJ. This was then subtracted from the background intensity to standardize
the expression across all sections to obtain the corrected intensity. For BDNF and CBP analysis, the DG was manually circled in
each brain section and the mean intensity of the fluorescently expressed markers was measured. These values were then averaged
across all sections for each animal. The same quantification was performed to measure osteocalcin in the CA3a region. For cFos+
neuron analysis, each individual cell expressing a cfos fluorescent marker was counted in each section of both hemispheres. These
numbers were then averaged based on the number of sections analyzed.
ChIP (Chromatin Immuno-Precipitation) and RNA Extraction Gene expression analysis
Fold enrichment was calculated using the 2-DDCt method.
Statistics
Statistics were performed with GraphPad Prism 6 software. Repeated-measures ANOVA (RMANOVA), ANOVA, and t tests were
used as indicated. The results are presented as means ± SEM. Statistical significance was set at p < 0.05. Full statistical analysis
can be found in Table S4, Detailed statistics for each figure related to all Figures).
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